APA (7th ed.) Citation

JK, H., P, G., E, S., S, W., L, H., M, Z., . . . D, R. (2021). C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease. Pharmacogenomics and personalized medicine, 14, 893. https://doi.org/10.2147/PGPM.S307827

Chicago Style (17th ed.) Citation

JK, Henes, et al. "C5 Variant Rs10985126 Is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease." Pharmacogenomics and Personalized Medicine 14 (2021): 893. https://doi.org/10.2147/PGPM.S307827.

MLA (9th ed.) Citation

JK, Henes, et al. "C5 Variant Rs10985126 Is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease." Pharmacogenomics and Personalized Medicine, vol. 14, 2021, p. 893, https://doi.org/10.2147/PGPM.S307827.